Affordable Access

Publisher Website

New lumbar Lordosing orthosis for degenerative lumbar conditions: clinical and experimental tests

Springer (Biomed Central Ltd.)
Publication Date
DOI: 10.1186/1748-7161-4-s2-p1
  • Poster Presentation
  • Design

Abstract ral ss BioMed CentScoliosis Open AccePoster presentation New lumbar Lordosing orthosis for degenerative lumbar conditions: clinical and experimental tests JF Salmochi*1, P Faouën2, J De Mauroy1, W Brossier2, F Munoz3, P Vallese1 and ETP Rougier3 Address: 1Clinique du Parc - 155 Bd Stalingrad 69006 Lyon, France, 2Prodos, 449 ch. Wette Fays 69300 Caluire, France and 3Université de Savoie 73376 Le Bourget du lac, France Email: JF Salmochi* - [email protected] * Corresponding author Background The need to limit discovertebral constraints without restricting the patient's everyday activities during episodes of lumbar pain has led to the production of a standard model brace. The brace's design and functions target sag- ittal balance through trunk reposition, spinal flexion reduction, and lordosis maintenance without putting pressure on the posterior joints. The 4 clinical and experi- mental studies presented below confirm the importance of this orthosis. Clinical test 1 objective The first objective is to evaluate the effects of wearing a LORDACTIV orthosis during pain experienced by patients suffering from degenerative lumbar conditions. Methods 113 patients suffering from lumbago were fitted with a corset (56 women and 57 men) with an average age of 42 years, presenting on average with 8 months of persistent lumbar pain or radiculitis (intensity 7.3/10 on the Visual Analog Scale). Simple X-rays and an MRI allowed the fol- lowing to be distinguished: discopathy (black appearance in T2 for discs L4L5 and/or L5S1), 44 cases, average age 38 years; inflammatory disc degeneration (MODIC 1) 21 cases, average age 50 years; disc hernia, 33 cases, average and no sick leave was given. Pain evaluation was assessed with the Visual Analog Scale. Results The VAS average result after 4 weeks was 1.5/10, represent- ing a pain reduction of 80%. The patients judged this result 'good' or 'very good' in 78% of cases. Regarding the different conditions

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times